Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.06 | 0.7 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.02 | 0.7 |